Cannabis Concept(BK4557),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4557 Cannabis Concept

Market Closed 02-20 16:00:00 EST

243.01

+0.04

+0.02%

High247.34	Low236.97	Vol34.08M
Open242.98	D1 Closing242.97	Amplitude4.26%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O413.19M	T/O Rate--	Tradable Shares0.00
P/B3.273983	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":243.013,"timestamp":1771621199999,"preClose":242.97266,"halted":0,"volume":34083144,"delay":0,"changeRate":0.000166,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0.040344,"latestTime":"02-20 16:00:00 EST","open":242.98355,"high":247.33505,"low":236.97287,"amount":413185163.425307,"amplitude":0.042648,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.273983,"peRate":-147.018123,"turnoverRate":0.011672,"increases":7,"decrements":8,"flats":1,"marketCap":58573583825.25,"floatMarketCap":52788287795.25},"requestUrl":"/m/hq/s/BK4557","defaultTab":"news","newsList":[{"id":"2613829408","title":"Teva Pharmaceutical Says FDA Accepts New Drug Application for Olanzapine in Schizophrenia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2613829408","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613829408?lang=en_us&edition=fundamental","pubTime":"2026-02-21 04:05","pubTimestamp":1771617940,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said Friday that the US Food and Drug Administration has accepted the company's New Drug Application for olanzapine extended-release injectable suspension, or TEV-'749, for the treatment of schizophrenia in adults.The application for TEV-'749 is based on results from the phase 3 Solaris trial that demonstrated an efficacy and safety profile consistent with other available olanzapine formulations, and showed no evidence for the need for post-injection monitoring, Teva Pharmaceutical Industries said.Shares of the company were down over 1% in recent Friday trading.Price: 34.00, Change: -0.33, Percent Change: -0.96","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","BK4596","LU2324357040.USD","BK4588","BK4584","LU1983299246.USD","BK4557","BK4566","BK4007","BK4585","TEVA"],"gpt_icon":0},{"id":"2613129475","title":"FDA accepts Teva NDA for olanzapine extended-release injectable suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2613129475","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613129475?lang=en_us&edition=fundamental","pubTime":"2026-02-21 03:55","pubTimestamp":1771617319,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Medincell announced that the U.S. Food and Drug Administr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-accepts-teva-nda-for-olanzapine-extended-release-injectable-suspension-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-accepts-teva-nda-for-olanzapine-extended-release-injectable-suspension-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","TEVA","BK4559","BK4007","BK4566","LU1983299246.USD","BK4596","BK4584","BK4557","LU2324357040.USD","BK4588"],"gpt_icon":0},{"id":"2613295236","title":"Dr. Reddy's Secures FDA Review for Abatacept Biologics License Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2613295236","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613295236?lang=en_us&edition=fundamental","pubTime":"2026-02-21 00:29","pubTimestamp":1771604952,"startTime":"0","endTime":"0","summary":"Dr. Reddy's Laboratories (RDY) said Friday the US Food and Drug Administration has accepted for review its biologics license application for an IV infusion formulation of DRL_AB, a proposed biosimilar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348744763.USD","BK4532","BK4557","BK4007","RDY.AU","RDY","BK4596","BK4523","BK7016"],"gpt_icon":0},{"id":"2612416298","title":"Aurora Innovation Years Ahead of Competitors, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2612416298","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612416298?lang=en_us&edition=fundamental","pubTime":"2026-02-20 23:06","pubTimestamp":1771600001,"startTime":"0","endTime":"0","summary":"Aurora Innovation  is years ahead of is competitors in creating fully self-driving on-road commercial vehicles, Oppenheimer analysts said in a note to clients Friday.\"We are encouraged by the efficiency of its technology foundation, which is enabling rapid Operating Design Domain expansion leveraging on-road experience and simulation capabilities,\" the analysts wrote.Oppenheimer said demand for the company's vehicles remains strong, and exceeds its planned production schedule. It also estimates savings of approximately 15% of driver expense, and fuel savings of 14% to 34%.\"It appears that AUR's unit economics would put non-automated carriers at a significant disadvantage which should further drive adoption,\" the analysts wrote.Price: 4.82, Change: -0.04, Percent Change: -0.93","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACB","BK4137","BK4557","BK4127","MSOS","AUR","BK7095","AUR.AU","BK4007","BK4023","OPY"],"gpt_icon":0},{"id":"2612261954","title":"Press Release: Green Thumb Industries Announces an Additional $50 Million Senior Debt Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2612261954","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612261954?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:00","pubTimestamp":1771588800,"startTime":"0","endTime":"0","summary":"CHICAGO and VANCOUVER, British Columbia, Feb. 20, 2026  -- Green Thumb Industries Inc.   , a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced the Company increased its existing syndicated credit facility led by Valley National Bank by $50 million, bringing the total facility to $189 million. The Company intends to use the cash proceeds for general corporate purposes, potential strategic investments, and other working capital requirements.\"Adding $50 million to our balance sheet at a low rate should be good for our shareholders long term,\" said Founder, Chairman and Chief Executive Officer Ben Kovler. \"We are fortunate to have Valley National Bank as a financing partner who has confidence in our business model and capital stewardship.\". The credit facility has a maturity date of September 11, 2029 and will continue to bear interest from the date of issue at Secured Overnight Financing Rate  + 500 basis points. This transaction did","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GTBIF","SOFR","BK4557"],"gpt_icon":0},{"id":"2612266926","title":"Amphastar Pharmaceuticals Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612266926?lang=en_us&edition=fundamental","pubTime":"2026-02-20 19:00","pubTimestamp":1771585216,"startTime":"0","endTime":"0","summary":"- **Q4 2025 earnings release:** Amphastar Pharmaceuticals, Inc. will release its fourth-quarter earnings results on **Thursday, February 26, 2026**, **after the market closes**. Results will be available on the Investors page at www.amphastar.com. - **Earnings conference call:** Amphastar will hold a conference call to discuss the results on **February 26, 2026 at 2:00 p.m. Pacific Time**, accessible via the Investors page at www.amphastar.com. **Bill Peters ** is listed as the contact.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL8ZCyLn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AMPH","BK4585","BK4007","BK4557"],"gpt_icon":0},{"id":"2612266173","title":"Hargreave Hale AIM VCT Expands Share Capital with New LSE Admissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612266173?lang=en_us&edition=fundamental","pubTime":"2026-02-20 18:43","pubTimestamp":1771584229,"startTime":"0","endTime":"0","summary":"Hargreave Hale AIM VCT 1 ( ($GB:HHV) ) has issued an announcement. Hargreave Hale AIM VCT PLC has increased its issued share capital through the ad...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hargreave-hale-aim-vct-expands-share-capital-with-new-lse-admissions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hargreave-hale-aim-vct-expands-share-capital-with-new-lse-admissions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIM","BK4139","LSE","BK4557","BK4179"],"gpt_icon":0},{"id":"2612239872","title":"SNDL Sets March 12 Release Date for Q4 and Full-Year 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2612239872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612239872?lang=en_us&edition=fundamental","pubTime":"2026-02-20 06:08","pubTimestamp":1771538932,"startTime":"0","endTime":"0","summary":"An announcement from SNDL ( ($SNDL) ) is now available. On February 19, 2026, SNDL Inc. said it will publish its fourth quarter and full-year 2025 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sndl-sets-march-12-release-date-for-q4-and-full-year-2025-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sndl-sets-march-12-release-date-for-q4-and-full-year-2025-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4547","BK4007","SNDL","BK4557"],"gpt_icon":0},{"id":"2612929235","title":"BRIEF-Corcept Says US Court Rules Teva's Generic Korlym Does Not Infringe Corcept Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2612929235","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612929235?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:35","pubTimestamp":1771536943,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Says US Court Rules Teva's Generic Korlym Does Not Infringe Corcept PatentsFeb 19 (Reuters) - Corcept Therapeutics Inc CORT.O:CORCEPT PROVIDES UPDATE ON PATENT DISPUTE WITH TEVA PHARMACE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUABQN0YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","LU2324357040.USD","BK4566","LU0566484027.USD","BK4007","BK4532","BK4588","CORT","BK4584","BK4585","LU1983299246.USD","LU1559883803.SGD","TEVA","BK4559","BK4557"],"gpt_icon":0},{"id":"2612235342","title":"SNDL Inc. Publishes Financial Calendar Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2612235342","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612235342?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:31","pubTimestamp":1771536667,"startTime":"0","endTime":"0","summary":"SNDL Inc. Publishes Financial Calendar Update               SNDL Inc. will release its fourth quarter 2025 and full year 2025 financial results before markets open on March 12, 2026. SNDL will host a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDLblDtj3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU2210149790.SGD","BK4585","SG9999014013.SGD","SG9999014005.SGD","SG9999014039.USD","SNDL","NDAQ","BK4007","BK4112","BK4557","BK4547","IE00B3QW5Z07.USD","LU2095319765.USD","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2612728001","title":"Corcept Therapeutics Inc - Ruling Affirms December 2023 Verdict by Federal District Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2612728001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612728001?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:00","pubTimestamp":1771534800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUABQN0YZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4596","LU2324357040.USD","BK4566","LU0566484027.USD","BK4007","BK4532","BK4588","CORT","BK4584","BK4585","LU1983299246.USD","LU1559883803.SGD","TEVA","BK4559","BK4557"],"gpt_icon":0},{"id":"2612280046","title":"Corcept Therapeutics Inc - Considering Judicial Review of Court Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2612280046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612280046?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:00","pubTimestamp":1771534800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUABQN0YZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4596","BK4559","LU2324357040.USD","TEVA","BK4007","BK4585","BK4588","LU1559883803.SGD","LU0566484027.USD","BK4532","BK4557","BK4584","CORT","BK4566","LU1983299246.USD"],"gpt_icon":0},{"id":"2612044280","title":"Corcept Provides Update on Patent Dispute With Teva Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2612044280","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612044280?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:00","pubTimestamp":1771534800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUABQN0YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4566","CORT","LU0566484027.USD","BK4557","BK4559","BK4584","BK4585","BK4588","LU1559883803.SGD","LU1983299246.USD","LU2324357040.USD","TEVA","BK4596","BK4007"],"gpt_icon":0},{"id":"2612288281","title":"Octopus AIM VCT 2 Tightens Share Base With Latest Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2612288281","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612288281?lang=en_us&edition=fundamental","pubTime":"2026-02-20 00:57","pubTimestamp":1771520244,"startTime":"0","endTime":"0","summary":"Octopus AIM VCT 2 ( ($GB:OSEC) ) has provided an update. Octopus AIM VCT 2 plc has bought back and cancelled 877,140 ordinary shares at 35.4697 pen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/octopus-aim-vct-2-tightens-share-base-with-latest-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/octopus-aim-vct-2-tightens-share-base-with-latest-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","AIM","BK4139"],"gpt_icon":0},{"id":"2612289286","title":"Organigram price target raised to C$4 from C$3 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2612289286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612289286?lang=en_us&edition=fundamental","pubTime":"2026-02-20 00:07","pubTimestamp":1771517232,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on Organigram (OGI) to C$4 from C$3 and keeps a Buy rating on the shares. Published first on TheFly – the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organigram-price-target-raised-to-c4-from-c3-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organigram-price-target-raised-to-c4-from-c3-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","OGI","BK4007"],"gpt_icon":0},{"id":"2612286398","title":"Neural Therapeutics Moves to Take Full Control of German CBD Retailer Hanf.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2612286398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612286398?lang=en_us&edition=fundamental","pubTime":"2026-02-19 23:07","pubTimestamp":1771513677,"startTime":"0","endTime":"0","summary":"An update from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics has applied to the Canadian Securities Exchange for a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neural-therapeutics-moves-to-take-full-control-of-german-cbd-retailer-hanf-com?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neural-therapeutics-moves-to-take-full-control-of-german-cbd-retailer-hanf-com?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4557","CBD","BK4139","BK4113","MSOS","ACB","BK4007","LENZ"],"gpt_icon":0},{"id":"2612828843","title":"What's Going On With Organigram Global Stock Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2612828843","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612828843?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:53","pubTimestamp":1771509180,"startTime":"0","endTime":"0","summary":"Organigram Global Inc.  shares rose in Thursday's premarket session after the company confirmed a 65.2 million Canadian dollar private placement investment from British American Tobacco's  subsidiary.The financing includes the subscription of 14,027,074 shares at 3.00 Canadian dollars per share  and exercise top-up rights for 9,897,356 shares at 2.335854 Canadian dollars per share , totaling 65.2 million Canadian dollars in gross proceeds.This follows Wednesday's disclosure that the company was in advanced negotiations for this same 65.2 million Canadian dollar investment.The confirmed investment strengthens Organigram's balance sheet and signals continued backing from British American Tobacco, which is already a shareholder in both Organigram and Sanity. That alignment reinforces confidence in the strategic rationale of building a global pure-play cannabis platform with expanded exposure to key European markets.The stock is currently trading 4.8% above its 20-day simple moving average","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/19/Munich--Bavaria--Germany---March-31-2023.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/19/Munich--Bavaria--Germany---March-31-2023.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50718308/whats-going-on-with-organigram-global-stock-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50718308/whats-going-on-with-organigram-global-stock-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4075","BK4217","OGI","BK4557","BK4585","LU2543165471.USD","BK4007","BK4588","BTI","SMA","LU0006061336.USD"],"gpt_icon":0},{"id":"2612729400","title":"Veru CEO Mitchell Steiner to Present at Oppenheimer Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2612729400","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612729400?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:32","pubTimestamp":1771507976,"startTime":"0","endTime":"0","summary":"Veru CEO Mitchell Steiner to Present at Oppenheimer Healthcare Life Sciences Conference               Veru Inc. (NASDAQ: VERU) said its Chairman, President and CEO Mitchell Steiner, M.D., will present","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL601bSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","BK4585","BK4588","BK4183","VERU","SG9999014013.SGD","IE00BGHQF748.EUR","LU0314104364.USD","BK4557","NDAQ","BK4007","SG9999014039.USD","IE00B64PRP62.GBP","LU2210150020.SGD","LU2095319765.USD","BK4112","BK4584","SG9999014005.SGD"],"gpt_icon":0},{"id":"2612245614","title":"Lighthouse Gold Launches Phase I Exploration at Aurora NW Project in Guyana","url":"https://stock-news.laohu8.com/highlight/detail?id=2612245614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612245614?lang=en_us&edition=fundamental","pubTime":"2026-02-19 05:32","pubTimestamp":1771450374,"startTime":"0","endTime":"0","summary":"Alerio Gold Corp ( ($TSE:LGHT) ) just unveiled an announcement. Lighthouse Gold Inc. is advancing its exploration strategy in Guyana’s Cuyuni green...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lighthouse-gold-launches-phase-i-exploration-at-aurora-nw-project-in-guyana?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lighthouse-gold-launches-phase-i-exploration-at-aurora-nw-project-in-guyana?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["518880","159934","MGCmain","SGCmain","GDX","IAU","DUST","MSOS","ACB","NUGT","SGUmain","BK4557","GCmain","BK4007"],"gpt_icon":0},{"id":"2612144715","title":"Unicorn AIM VCT Cancels 2.5 Million Shares in Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2612144715","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612144715?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:27","pubTimestamp":1771432045,"startTime":"0","endTime":"0","summary":"Unicorn AIM VCT ( ($GB:UAV) ) has provided an announcement. Unicorn AIM VCT PLC has executed a share buyback, purchasing 2,515,831 of its own ordin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/unicorn-aim-vct-cancels-2-5-million-shares-in-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/unicorn-aim-vct-cancels-2-5-million-shares-in-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4557","AIM"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4557","nameEN":"BK4557"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cannabis Concept(BK4557),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cannabis Concept(BK4557) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cannabis Concept,BK4557,Cannabis Concept股票,Cannabis Concept股票老虎,Cannabis Concept股票老虎国际,Cannabis Concept行情,Cannabis Concept股票行情,Cannabis Concept股价,Cannabis Concept股市,Cannabis Concept股票价格,Cannabis Concept股票交易,Cannabis Concept股票购买,Cannabis Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cannabis Concept(BK4557),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cannabis Concept(BK4557) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}